{"DataElement":{"publicId":"2481660","version":"1","preferredName":"Prior Cancer Diagnosis Text Type","preferredDefinition":"The text that describes the type of prior tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues the participant has experienced.","longName":"PRIOR_CA_DX_TXT_TP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2010134","version":"4","preferredName":"Prior Cancer Diagnosis","preferredDefinition":"information related to a prior cancer diagnosis.","longName":"PRIOR_CA_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206692","version":"1","preferredName":"Prior Malignant Neoplasm","preferredDefinition":"Earlier in time or order.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25629:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-003B-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E67BAAB3-1B9E-4FCD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-15","modifiedBy":"GDEEN","dateModified":"2023-05-04","changeDescription":"3/2/22 jk added RS.  --- ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2481658","version":"1","preferredName":"Prior Cancer Diagnosis Text Type","preferredDefinition":"The text that describes the type of prior tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues the participant has experienced.","longName":"PRIOR_CA_DX_TXT_TP","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Invasive Breast Cancer","valueDescription":"Invasive breast cancer","ValueMeaning":{"publicId":"2576315","version":"1","preferredName":"Invasive breast cancer","longName":"2576315","preferredDefinition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma","conceptCode":"C9245","definition":"A carcinoma that infiltrates the breast parenchyma.  The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU).  Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ.  It is the most common carcinoma affecting women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F728-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ZHANGW","dateModified":"2021-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EA553F-FD73-1CB8-E044-0003BA3F9857","beginDate":"2006-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-16","modifiedBy":"MAESKEB","dateModified":"2006-05-16","deletedIndicator":"No"},{"value":"Unilateral DCIS","valueDescription":"Unilateral DCIS","ValueMeaning":{"publicId":"2579302","version":"1","preferredName":"Unilateral DCIS","longName":"2579302","preferredDefinition":"Unilateral DCIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-02D3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-16","modifiedBy":"MAESKEB","dateModified":"2006-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EA553F-FD7F-1CB8-E044-0003BA3F9857","beginDate":"2006-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-16","modifiedBy":"MAESKEB","dateModified":"2006-05-16","deletedIndicator":"No"},{"value":"Atypical Hyperplasia","valueDescription":"Atypical Hyperplasia","ValueMeaning":{"publicId":"2573744","version":"1","preferredName":"Atypical Hyperplasia","longName":"2573744","preferredDefinition":"A benign (noncancerous) condition in which tissue has certain abnormal features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Hyperplasia","conceptCode":"C8355","definition":"A benign (noncancerous) condition in which tissue has certain abnormal features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED1D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-23","modifiedBy":"MAESKEB","dateModified":"2005-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1BB09712-DCDD-3077-E044-0003BA3F9857","beginDate":"2006-08-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-23","modifiedBy":"MAESKEB","dateModified":"2006-08-23","deletedIndicator":"No"},{"value":"BRCA 1","valueDescription":"BRCA1","ValueMeaning":{"publicId":"2580435","version":"1","preferredName":"BRCA1","longName":"2580435","preferredDefinition":"Breast Cancer 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0740-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-04","modifiedBy":"MAESKEB","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E026C1F-F3FE-360F-E044-0003BA3F9857","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-13","modifiedBy":"MAESKEB","dateModified":"2007-04-13","deletedIndicator":"No"},{"value":"Unilateral LCIS","valueDescription":"Unilateral LCIS","ValueMeaning":{"publicId":"2626420","version":"1","preferredName":"Unilateral LCIS","longName":"2626420","preferredDefinition":"Unilateral LCIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E026C1F-F40A-360F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E026C1F-F424-360F-E044-0003BA3F9857","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-13","modifiedBy":"MAESKEB","dateModified":"2007-04-13","deletedIndicator":"No"},{"value":"BRCA 2","valueDescription":"BRCA2","ValueMeaning":{"publicId":"2580436","version":"1","preferredName":"BRCA2","longName":"2580436","preferredDefinition":"Breast Cancer 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0741-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-04","modifiedBy":"MAESKEB","dateModified":"2007-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E026C1F-F43B-360F-E044-0003BA3F9857","beginDate":"2007-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-13","modifiedBy":"MAESKEB","dateModified":"2007-04-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207966","version":"1","preferredName":"Text Type","preferredDefinition":"Text; the words of something written.:Type; a subdivision of a particular kind of thing.","longName":"C25704:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-36EC-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13EA53A2-F09F-1C0B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-16","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Prior Diagnosis","type":"Preferred Question Text","description":"Prior Diagnosis","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"13EA53A2-F0B4-1C0B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-16","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}